DownRightNowNews
Trending
Times Square Police Shooting Was Justified but Put Others at Risk, Experts SayIran war live: US bombs Iran, Tehran retaliates on Gulf neighbours, JordanIran Attacks US Base In Jordan In Retaliation: ReportBreather for creditors: New NCLT bench stays the approval of a repayment plan proposed by Subhash ChandraJharkhand SIR faceoff: BJP agents seek to delete voters, Booth Level Officers raise red flagDismantle ‘entire ecosystem of terrorism’: PM Modi says no country should use terror as strategic assetNehru Back On His Pedestal: Did Congress's 24-Hour Ultimatum Force Midnight Reinstallation In Bengal's DurgWidow gets husband’s provident fund and gratuity but loses family pension due to a paperwork mistakeTimes Square Police Shooting Was Justified but Put Others at Risk, Experts SayIran war live: US bombs Iran, Tehran retaliates on Gulf neighbours, JordanIran Attacks US Base In Jordan In Retaliation: ReportBreather for creditors: New NCLT bench stays the approval of a repayment plan proposed by Subhash ChandraJharkhand SIR faceoff: BJP agents seek to delete voters, Booth Level Officers raise red flagDismantle ‘entire ecosystem of terrorism’: PM Modi says no country should use terror as strategic assetNehru Back On His Pedestal: Did Congress's 24-Hour Ultimatum Force Midnight Reinstallation In Bengal's DurgWidow gets husband’s provident fund and gratuity but loses family pension due to a paperwork mistake
Business

Diageo To Overhaul Whisky, Rum Formulas In India To Settle Regulatory Probe: Report

·18 Aug
Share:PostShare

Among the affected Diageo products are McDowell's No. 1 Celebration Matured XXX Rum in Maharashtra and Antiquity Blue and Royal Challenge whisky in Madhya Pradesh.

N

Ndtv

Original source

Read full story

bloombergquint

Check live status on DownRightNow

Check status →
World

Related Stories

Business57m ago

Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impact

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affordable for low-income Americans. Analysts believe the financial impact on Sun Pharma will be minimal. The company's US revenue contribution is significant, reinforcing its growth strategy. This pact recognizes Sun Pharma's investment in the American market.

TThe Economic Times

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer